Skip to main content
. 2015 Mar 11;10(3):e0117855. doi: 10.1371/journal.pone.0117855

Table 2. Summary of the advantages and disadvantages of uncultured MSCs for clinical applications.

Factor Advantage Disadvantage
Safety Potential of spontaneous transformation and transfer of animal pathogens [911] is limited by avoiding in vitro culture. Potential carry-over of undesirable phenotypic characteristics in case of FH [57,58].
Purity Cells are not subject to in vitro aging associated with culture expansion [8,59], therefore no or minimal loss of native phenotypic [21,60] and functional characteristics. Currently-achieved purity levels are unlikely to be sufficient for allogeneic use.
Cost Reduced cost due to lower regulatory burden [12] and reduced use of GMP-grade culture facilities and reagents. Total cost is dependent on the application and the numbers of MSCs required; these may be limited by the source material.
Time Cells are ready for use within hours and do not require a lengthy expansion period. For autologous use extraction/enrichment procedure must fit with intraoperative time frame.